Engineering Glyco‐Enzymes for Substrate Identification and Targeting

[1]  S. Wisnovsky,et al.  Bridging Glycomics and Genomics: New Uses of Functional Genetics in the Study of Cellular Glycosylation , 2022, Frontiers in Molecular Biosciences.

[2]  Chun-Chun Wang,et al.  Cell-type-specific labeling and profiling of glycans in living mice , 2022, Nature Chemical Biology.

[3]  Alexandria K. D’Souza,et al.  Writing and Erasing O-GlcNAc on Casein Kinase 2 Alpha Alters the Phosphoproteome. , 2022, ACS chemical biology.

[4]  A. Griffiths,et al.  Mucus sialylation determines intestinal host-commensal homeostasis , 2022, Cell.

[5]  J. Hanover,et al.  Tools, tactics and objectives to interrogate cellular roles of O-GlcNAc in disease , 2021, Nature Chemical Biology.

[6]  D. Weiner,et al.  Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells , 2021, PLoS pathogens.

[7]  H. Wandall,et al.  Global functions of O‐glycosylation: promises and challenges in O‐glycobiology , 2021, The FEBS journal.

[8]  C. Bertozzi,et al.  Cell-specific Bioorthogonal Tagging of Glycoproteins , 2021, bioRxiv.

[9]  Jennifer J. Kohler,et al.  A photo-cross-linking GlcNAc analog enables covalent capture of N-linked glycoprotein-binding partners on the cell surface. , 2021, Cell chemical biology.

[10]  Pedro J. Batista,et al.  Small RNAs are modified with N-glycans and displayed on the surface of living cells , 2021, Cell.

[11]  C. Bertozzi,et al.  Optimization of Metabolic Oligosaccharide Engineering with Ac4GalNAlk and Ac4GlcNAlk by an Engineered Pyrophosphorylase , 2021, ACS chemical biology.

[12]  B. Walker,et al.  HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses. , 2021, Cell host & microbe.

[13]  Alexandria K. D’Souza,et al.  Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase , 2021, Nature Chemical Biology.

[14]  L. Wells,et al.  Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc cycling enzymes OGT and OGA. , 2021, Glycobiology.

[15]  N. Gray,et al.  Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase , 2020, Proceedings of the National Academy of Sciences.

[16]  Xi Chen,et al.  Recent progress in synthesis of carbohydrates with sugar nucleotide-dependent glycosyltransferases. , 2020, Current opinion in chemical biology.

[17]  C. Bertozzi,et al.  Targeted glycan degradation potentiates the anticancer immune response in vivo , 2020, Nature Chemical Biology.

[18]  Jennifer J. Kohler,et al.  Mass spectrometric method for the unambiguous profiling of cellular dynamic glycosylation , 2020, bioRxiv.

[19]  Xing Chen,et al.  Protein S-Glyco-Modification Through an Elimination-Addition Mechanism. , 2020, Journal of the American Chemical Society.

[20]  Gaelen T. Hess,et al.  Metabolic precision labeling enables selective probing of O-linked N-acetylgalactosamine glycosylation , 2020, Proceedings of the National Academy of Sciences.

[21]  Jennifer J. Kohler,et al.  Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells , 2020, Molecular cell.

[22]  Hung-Yi Wu,et al.  Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells. , 2020, ACS chemical biology.

[23]  J. Paulson,et al.  Siglecs as Immune Cell Checkpoints in Disease. , 2020, Annual review of immunology.

[24]  D. V. van Aalten,et al.  Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation , 2019, Nature Structural & Molecular Biology.

[25]  Xing Chen,et al.  Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells , 2019, Nature Communications.

[26]  D. V. van Aalten,et al.  Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability , 2019, Proceedings of the National Academy of Sciences.

[27]  A. Varki,et al.  An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells. , 2019, Molecular cell.

[28]  C. Bertozzi,et al.  Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs. , 2019, Journal of the American Chemical Society.

[29]  R. Hurtado-Guerrero,et al.  Polypeptide GalNAc-Ts: from redundancy to specificity. , 2019, Current opinion in structural biology.

[30]  Xi Chen,et al.  Strategies for chemoenzymatic synthesis of carbohydrates. , 2019, Carbohydrate research.

[31]  Damien Y. Duveau,et al.  Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors. , 2018, Journal of the American Chemical Society.

[32]  K. Islam.  The Bump-and-Hole Tactic: Expanding the Scope of Chemical Genetics. , 2018, Cell chemical biology.

[33]  Chao Li,et al.  Chemoenzymatic Methods for the Synthesis of Glycoproteins. , 2018, Chemical reviews.

[34]  Marc R. Hayes,et al.  Synthesis of Glycosides by Glycosynthases , 2017, Molecules.

[35]  Mark M. Davis,et al.  Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells , 2016, The Journal of Immunology.

[36]  Wei Zhao,et al.  An OGA-Resistant Probe Allows Specific Visualization and Accurate Identification of O-GlcNAc-Modified Proteins in Cells. , 2016, ACS chemical biology.

[37]  Carolyn R Bertozzi,et al.  Precision glycocalyx editing as a strategy for cancer immunotherapy , 2016, Proceedings of the National Academy of Sciences.

[38]  Igor Rudan,et al.  Mechanisms of disease: The human N-glycome. , 2016, Biochimica et biophysica acta.

[39]  R. Huganir,et al.  The nutrient sensor OGT in PVN neurons regulates feeding , 2016, Science.

[40]  C. Bertozzi,et al.  Chemical Glycoproteomics. , 2016, Chemical reviews.

[41]  H. Wandall,et al.  Deconstruction of O‐glycosylation—GalNAc‐T isoforms direct distinct subsets of the O‐glycoproteome , 2015, EMBO reports.

[42]  S. Pinho,et al.  Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.

[43]  G. Adema,et al.  Sialic Acid Glycoengineering Using an Unnatural Sialic Acid for the Detection of Sialoglycan Biosynthesis Defects and On-Cell Synthesis of Siglec Ligands. , 2015, ACS chemical biology.

[44]  J. Paulson,et al.  Siglec-mediated regulation of immune cell function in disease , 2014, Nature Reviews Immunology.

[45]  V. Piller,et al.  Changes in Metabolic Chemical Reporter Structure Yield a Selective Probe of O-GlcNAc Modification , 2014, Journal of the American Chemical Society.

[46]  Stephen M. Canham,et al.  Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion , 2013, Nature chemical biology.

[47]  S. Jha,et al.  Inhibition of mucin-type O-glycosylation through metabolic processing and incorporation of N-thioglycolyl-D-galactosamine peracetate (Ac5GalNTGc). , 2013, Journal of the American Chemical Society.

[48]  Junfeng Ma,et al.  Protein O-GlcNAcylation in diabetes and diabetic complications , 2013, Expert review of proteomics.

[49]  Chi‐Huey Wong,et al.  6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin type-1 repeats by protein O-fucosyltransferases 1 and 2. , 2013, Glycobiology.

[50]  M. Altfeld,et al.  Evasion from NK cell-mediated immune responses by HIV-1. , 2012, Microbes and infection.

[51]  Linda C Hsieh-Wilson,et al.  Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism , 2012, Science.

[52]  Stuart M Haslam,et al.  Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. , 2012, Nature chemical biology.

[53]  A. Varki,et al.  Multifarious roles of sialic acids in immunity , 2012, Annals of the New York Academy of Sciences.

[54]  Jennifer J. Kohler,et al.  Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners , 2012, Proceedings of the National Academy of Sciences.

[55]  V. Piller,et al.  Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway. , 2012, ACS chemical biology.

[56]  G. Hart,et al.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. , 2011, Annual review of biochemistry.

[57]  H. Hang,et al.  Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1 , 2011, Proceedings of the National Academy of Sciences.

[58]  Jennifer J. Kohler,et al.  Metabolic cross-talk allows labeling of O-linked β-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway , 2011, Proceedings of the National Academy of Sciences.

[59]  D. Vocadlo,et al.  Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells , 2011, Nature chemical biology.

[60]  Jian Du,et al.  Metabolic glycoengineering: sialic acid and beyond. , 2009, Glycobiology.

[61]  Richard D. Cummings,et al.  The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.

[62]  Y. Levy,et al.  Effect of glycosylation on protein folding: A close look at thermodynamic stabilization , 2008, Proceedings of the National Academy of Sciences.

[63]  Lewis L Lanier,et al.  Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.

[64]  Chi‐Huey Wong,et al.  Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells , 2007, Proceedings of the National Academy of Sciences.

[65]  M. Fukuda,et al.  Galectin-1 Binds Different CD43 Glycoforms to Cluster CD43 and Regulate T Cell Death1 , 2006, The Journal of Immunology.

[66]  C. Bertozzi,et al.  A chemical reporter strategy to probe glycoprotein fucosylation. , 2006, Journal of the American Chemical Society.

[67]  P. Angel,et al.  AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.

[68]  Scott B Ficarro,et al.  Parallel identification of O-GlcNAc-modified proteins from cell lysates. , 2004, Journal of the American Chemical Society.

[69]  Carolyn R. Bertozzi,et al.  Chemical remodelling of cell surfaces in living animals , 2004, Nature.

[70]  Jennifer J. Kohler,et al.  Regulating cell surface glycosylation by small molecule control of enzyme localization. , 2003, Chemistry & biology.

[71]  Chong Yu,et al.  A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Bertozzi,et al.  Metabolic oligosaccharide engineering as a tool for glycobiology. , 2003, Current opinion in chemical biology.

[73]  Carolyn R Bertozzi,et al.  A chemical approach for identifying O-GlcNAc-modified proteins in cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.

[75]  P. Ferrari,et al.  Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture , 2001, The EMBO journal.

[76]  Chi‐Huey Wong,et al.  Synthesis of complex carbohydrates and glycoconjugates: enzyme-based and programmable one-pot strategies. , 2000, Chemical reviews.

[77]  C. Bertozzi,et al.  Cell surface engineering by a modified Staudinger reaction. , 2000, Science.

[78]  A. Elbein,et al.  A 17-Amino Acid Insert Changes UDP-N-Acetylhexosamine Pyrophosphorylase Specificity from UDP-GalNAc to UDP-GlcNAc* , 1998, The Journal of Biological Chemistry.

[79]  J. Sodroski,et al.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.

[80]  C. Bertozzi,et al.  Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. , 1997, Science.

[81]  K. Shokat,et al.  Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[82]  K. Petry,et al.  Molecular cloning, characterization, and mapping of a full-length cDNA encoding human UDP-galactose 4'-epimerase. , 1995, Biochemical and molecular medicine.

[83]  J. Dennis,et al.  Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin , 1982, Nature.